Baton Rouge-based OncBioMune Pharmaceuticals is acquiring a generic drug that treats low blood pressure and heart failure from the Israel-based multinational pharmaceutical firm, Teva Pharmaceuticals …
Already an INSIDER? Sign in.
We are glad you enjoy reading Business Report.
Continue reading this story and get ACCESS to all our content from any device with a subscription now.
- Get access to more than a decade of story archives.
- Get access to our searchable data center of TOP LISTS.
- Get exclusive content only available to INSIDERS.